Literature DB >> 10785538

Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.

C J Hillard1.   

Abstract

The purpose of this review is to discuss the cellular synthesis and inactivation of two putative endogenous ligands of the cannabinoid receptor, N-arachidonylethanolamine (AEA) and 2-arachidonylglycerol (2-AG). Both ligands are synthesized by neurons and brain tissue in response to increased intracellular calcium concentrations. Both ligands are substrates for fatty acid amide hydrolase (FAAH). Both AEA and 2-AG bind to the neuronal form of the cannabinoid receptor (CB1). AEA binds the receptor with moderate affinity and has the characteristics of a partial agonist, whereas, 2-AG binds with low affinity but exhibits full efficacy. Two possible physiological roles of the endocannabinoids and the CB1 receptor are discussed: the regulation of gestation and the regulation of gastrointestinal motility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785538     DOI: 10.1016/s0090-6980(00)00051-4

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  73 in total

1.  Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling.

Authors:  Nathan K Evanson; Jeffrey G Tasker; Matthew N Hill; Cecilia J Hillard; James P Herman
Journal:  Endocrinology       Date:  2010-08-11       Impact factor: 4.736

Review 2.  Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know.

Authors:  Bradley E Alger
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

3.  Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.

Authors:  B S Wong; M Camilleri; D Eckert; P Carlson; M Ryks; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2012-01-30       Impact factor: 3.598

4.  Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Authors:  Iryna A Khasabova; Sergey Khasabov; Justin Paz; Catherine Harding-Rose; Donald A Simone; Virginia S Seybold
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

Review 5.  Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling.

Authors:  Yuki Sugaya; Masanobu Kano
Journal:  Cell Mol Life Sci       Date:  2018-05-08       Impact factor: 9.261

6.  Endocannabinoids and their implications for epilepsy.

Authors:  Bradley E Alger
Journal:  Epilepsy Curr       Date:  2004 Sep-Oct       Impact factor: 7.500

7.  Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.

Authors:  Matthew N Hill; Erica J Carrier; Ryan J McLaughlin; Anna C Morrish; Sarah E Meier; Cecilia J Hillard; Boris B Gorzalka
Journal:  J Neurochem       Date:  2008-07-15       Impact factor: 5.372

Review 8.  Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation.

Authors:  Sachin Patel; Cecilia J Hillard
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

Review 9.  Cellular accumulation of anandamide: consensus and controversy.

Authors:  Cecilia J Hillard; Abbas Jarrahian
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

Review 10.  Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids.

Authors:  Matthew N Hill; Bruce S McEwen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-11-10       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.